Claspin Overexpression Promotes Tumor Progression and Predicts Poor Clinical Outcome in Prostate Cancer-Reference-Cited by-同舟云学术

Claspin Overexpression Promotes Tumor Progression and Predicts Poor Clinical Outcome in Prostate Cancer

Published:2021-02-01 Issue:2 Volume:25 Page:131-139
ISSN:1945-0265
Container-title:Genetic Testing and Molecular Biomarkers
language:en
Short-container-title:Genetic Testing and Molecular Biomarkers

Author:

Cai Chao¹,Luo Jiexin²,Liu Qinwei¹,Liu Zezhen,Zhao Yan¹,Wu Xiangkun¹,Yuegao Yuanzhi¹,Lei Yeci¹,Lu Jianming³,Wang Ying⁴,Cai Zhouda⁵,Duan Xiaolu¹,Lei Ming¹,Gu Di¹,Liu Yongda¹

Affiliation:

1. Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University and Guangdong Key Laboratory of Urology, Guangzhou, China.

2. Department of Urology, Affiliated Dongguan People's Hospital, Southern Medical University, Dongguan, China.

3. Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Department of Urology, Guangzhou First People's Hospital, Guangzhou, China.

4. Medical Ultrasound Department, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

5. Department of Andrology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics(clinical),General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/gtmb.2020.0226

Reference27 articles.

1. DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients

2. Nascent Transcription ofMCM2-7Is Important for Nuclear Localization of the Minichromosome Maintenance Complex in G1

3. CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer